Skip to main content
SpringerLink
Log in

Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc Min/+ mouse model

  • Original Article – Cancer Research
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Naringin is a natural dietary flavonoid compound. We aimed to evaluate the effects of naringin on intestinal tumorigenesis in the adenomatous polyposis coli multiple intestinal neoplasia (Apc Min/+) mouse model.

Methods

Apc Min/+ mice were given either naringin (150 mg/kg) or vehicle by p.o. gavage daily for 12 consecutive weeks. Mice were killed with ether, and blood samples were collected to assess the concentrations of IL-6 and PGE2. Total intestines were removed, and the number of polyps was examined. Tissue samples of intestinal polyps were subjected to the assays of histopathology, immunohistochemical analysis and Western blotting analysis.

Results

Apc Min/+ mice fed with naringin developed less and smaller polyps in total intestines. Naringin prevented intestinal tumorigenesis without adverse effects. Histopathologic analysis revealed the reduction of dysplastic cells and dysplasia in the adenomatous polyps. The treatments’ effects might arise from its anti-proliferation, induction of apoptosis and modulation of GSK-3β and APC/β-catenin signaling pathways. Naringin also exerted its effects on tumorigenesis through anti-chronic inflammation.

Conclusion

Naringin prevented intestinal tumorigenesis likely through a collection of activities including anti-proliferation, induction of apoptosis, modulation of GSK-3β and APC/β-catenin pathways and anti-inflammation. Naringin is a potential chemopreventive agent for reducing the risk of colonic cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Adeniyi AO, Olubolade AO, Owira PM (2015) Naringin mitigates cardiac hypertrophy by reducing oxidative stress and inactivating c-Jun Nuclear Kinase (JNK-1) protein in type I diabetes. J Cardiovasc Pharmacol. doi:10.1097/FJC.0000000000000325

    Google Scholar 

  • Adil M, Kandhare AD, Visnagri A, Bodhankar SL (2015) Naringin ameliorates sodium arsenite-induced renal and hepatic toxicity in rats: decisive role of KIM-1, Caspase-3, TGF-β, and TNF-α. Ren Fail 37:1396–1407

    Article  PubMed  Google Scholar 

  • Annema N, Heyworth JS, McNaughton SA, Iacopetta B, Fritschi L (2011) Fruit and vegetable consumption and the risk of proximal colon, distal colon, and rectal cancers in a case–control study in Western Australia. J Am Diet Assoc 111:1479–1490

    Article  PubMed  Google Scholar 

  • Arvelo F, Sojo F, Cotte C (2015) Biology of colorectal cancer. Ecancermedicalscience 9:520

    Article  PubMed  PubMed Central  Google Scholar 

  • Banjerdpongchai R, Wudtiwai B, Khaw-On P, Rachakhom W, Duangnil N, Kongtawelert P (2015) Hesperidin from Citrus seed induces human hepatocellular carcinoma HepG2 cell apoptosis via both mitochondrial and death receptor pathways. Tumour Biol. doi:10.1007/s13277-015-3774-7

    PubMed  Google Scholar 

  • Boo JH, Song H, Kim JE, Kang DE, Mook-Jung I (2009) Accumulation of phosphorylated β-catenin enhances ROS-induced cell death in presenilin-deficient cells. PLoS ONE 4:e4172

    Article  PubMed  PubMed Central  Google Scholar 

  • Bosman F, Yan P (2014) Molecular pathology of colorectal cancer. Pol J Pathol 65:257–266

    Article  PubMed  Google Scholar 

  • Cheung KL, Lee JH, Khor TO, Wu TY, Li GX, Chan J, Yang CS, Kong AN (2014) Nrf2 knockout enhances intestinal tumorigenesis in Apc(min/+) mice due to attenuation of anti-oxidative stress pathway while potentiates inflammation. Mol Carcinog 53:77–84

    Article  CAS  PubMed  Google Scholar 

  • Chtourou Y, Aouey B, Kebieche M, Fetoui H (2015) Protective role of naringin against cisplatin induced oxidative stress, inflammatory response and apoptosis in rat striatum via suppressing ROS-mediated NF-κB and P53 signaling pathways. Chem Biol Interact 239:76–86

    Article  CAS  PubMed  Google Scholar 

  • Cordenonsi LM, Bromberger NG, Raffin RP, Scherman EE (2015) Simultaneous separation and sensitive detection of naringin and naringenin in nanoparticles by chromatographic method indicating stability and photodegradation kinetics. Biomed Chromatogr. doi:10.1002/bmc.3531

    PubMed  Google Scholar 

  • Diab S, Fidanzi C, Léger DY, Ghezali L, Millot M, Martin F, Azar R, Esseily F, Saab A, Sol V et al (2015) Berberis libanotica extract targets NF-κB/COX-2, PI3K/Akt and mitochondrial/caspase signalling to induce human erythroleukemia cell apoptosis. Int J Oncol 47:220–230

    PubMed  Google Scholar 

  • Fujisawa T, Sugiyama M, Tomimoto A, Wada K, Endo H, Takahashi H, Yoneda K, Yoneda M, Inamori M, Saito S (2008) Inhibition of peroxisome proliferator-activated receptor gamma promotes tumorigenesis through activation of the beta-catenin/T cell factor (TCF) pathway in the mouse intestine. J Pharmacol Sci 108:535–544

    Article  CAS  PubMed  Google Scholar 

  • Greene ER, Huang S, Serhan CN, Panigrahy D (2011) Regulation of inflammation in cancer by eicosanoids. Prostaglandins Other Lipid Mediat 96:27–36

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Huang J, Zhang D, Xie F, Lin D (2015) The potential role of COX-2 in cancer stem cell-mediated canine mammary tumor initiation: an immunohistochemical study. J Vet Sci 16:225–231

    Article  PubMed  PubMed Central  Google Scholar 

  • Jamieson T, Clarke M, Steele CW, Samuel MS, Neumann J, Jung A, Huels D, Olson MF, Das S, Nibbs RJ et al (2012) Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J Clin Invest 122:3127–3144

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Khare V, Dammann K, Asboth M, Krnjic A, Jambrich M, Gasche C (2015) Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer. Inflamm Bowel Dis 21:287–296

    Article  PubMed  PubMed Central  Google Scholar 

  • Klampfer L (2011) Cytokines, inflammation and colon cancer. Curr Cancer Drug Targets 11:451–464

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kulasekaran G, Ganapasam S (2015) Neuroprotective efficacy of naringin on 3-nitropropionic acid-induced mitochondrial dysfunction through the modulation of Nrf2 signaling pathway in PC12 cells. Mol Cell Biochem 409:199–211

    Article  CAS  PubMed  Google Scholar 

  • Kumar A, Pandurangan AK, Lu F, Fyrst H, Zhang M, Byun HS, Bittman R, Saba JD (2012) Chemopreventive sphingadienes downregulate Wnt signaling via a PP2A/Akt/GSK3β pathway in colon cancer. Carcinogenesis 33:1726–1735

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kwong LN, Dove WF (2009) APC and its modifiers in colon cancer. Adv Exp Med Biol 656:85–106

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee J, Kim JC, Lee SE, Quinley C, Kim H, Herdman S, Corr M, Raz E (2012) Signal transducer and activator of transcription 3 (STAT3) protein suppresses adenoma-to-carcinoma transition in Apcmin/+ mice via regulation of Snail-1 (SNAI) protein stability. J Biol Chem 287:18182–18189

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Leoz ML, Carballal S, Moreira L, Ocaña T, Balaguer F (2015) The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management. Appl Clin Genet 8:95–107

    CAS  PubMed  PubMed Central  Google Scholar 

  • Lewinska A, Siwak J, Rzeszutek I, Wnuk M (2015) Diosmin induces genotoxicity and apoptosis in DU145 prostate cancer cell line. Toxicol In Vitro 29:417–425

    Article  CAS  PubMed  Google Scholar 

  • Li H, Yang B, Huang J, Xiang T, Yin X, Wan J, Luo F, Zhang L, Li H, Ren G (2013) Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting β-catenin signaling pathway. Toxicol Lett 220:219–228

    Article  CAS  PubMed  Google Scholar 

  • Liu HP, Gao ZH, Cui SX, Wang Y, Li BY, Lou HX, Qu XJ (2013) Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice. Int J Cancer 132:2667–2681

    Article  CAS  PubMed  Google Scholar 

  • McAlpine CA, Barak Y, Matise I, Cormier RT (2006) Intestinal-specific PPARgamma deficiency enhances tumorigenesis in ApcMin/+ mice. Int J Cancer 119:2339–2346

    Article  CAS  PubMed  Google Scholar 

  • Meidenbauer JJ, Ta N, Seyfried TN (2014) Influence of a ketogenic diet, fish-oil, and calorie restriction on plasma metabolites and lipids in C57BL/6J mice. Nutr Metab (Lond) 11:23

    Article  PubMed  PubMed Central  Google Scholar 

  • Merritt AJ, Gould KA, Dove WF (1997) Polyclonal structure of intestinal adenomas in ApcMin/+ mice with concomitant loss of Apc+ from all tumor lineages. Proc Natl Acad Sci USA 94:13927–13931

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • O’Callaghan G, Kelly J, Shanahan F, Houston A (2008) Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells. Br J Cancer 99:502–512

    Article  PubMed  PubMed Central  Google Scholar 

  • Pierre CC, Longo J, Mavor M, Milosavljevic SB, Chaudhary R, Gilbreath E, Yates C, Daniel JM (2015) Kaiso overexpression promotes intestinal inflammation and potentiates intestinal tumorigenesis in ApcMin/+ mice. Biochim Biophys Acta 1852:1846–1855

    Article  CAS  PubMed  Google Scholar 

  • Qi Z, Xu Y, Liang Z, Li S, Wang J, Wei Y, Dong B (2015) Naringin ameliorates cognitive deficits via oxidative stress, proinflammatory factors and the PPARγ signaling pathway in a type 2 diabetic rat model. Mol Med Rep. doi:10.3892/mmr.2015.4232

    Google Scholar 

  • Raha S, Yumnam S, Hong GE, Lee HJ, Saralamma VV, Park HS, Heo JD, Lee SJ, Kim EH, Kim JA, Kim GS (2015) Naringin induces autophagy-mediated growth inhibition by downregulating the PI3K/Akt/mTOR cascade via activation of MAPK pathways in AGS cancer cells. Int J Oncol 47:1061–1069

    PubMed  Google Scholar 

  • Rajamanickam S, Velmurugan B, Kaur M, Singh RP, Agarwal R (2010) Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin. Cancer Res 70:2368–2378

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rigby RJ, Simmons JG, Greenhalgh CJ, Alexander WS, Lund PK (2007) Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon. Oncogene 26:4833–4841

    Article  CAS  PubMed  Google Scholar 

  • Schneikert J, Vijaya Chandra SH, Ruppert JG, Ray S, Wenzel EM, Behrens J (2013) Functional comparison of human adenomatous polyposis coli (APC) and APC-like in targeting beta-catenin for degradation. PLoS ONE 8:e68072

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shih IM, Wang TL, Traverso G, Romans K, Hamilton SR, Ben-Sasson S, Kinzler KW, Vogelstein B (2001) Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci USA 98:2640–2645

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tarapore RS, Siddiqui IA, Mukhtar H (2012) Modulation of Wnt/β-catenin signaling pathway by bioactive food components. Carcinogenesis 33:483–491

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • van Noort M, Meeldijk J, van der Zee R, Destree O, Clevers H (2002) Wnt signaling controls the phosphorylation status of beta-catenin. J Biol Chem 277:17901–17905

    Article  PubMed  Google Scholar 

  • Wang R, Wang Y, Gao Z, Qu X (2014) The comparative study of acetyl-11-keto-beta-boswellic acid (AKBA) and aspirin in the prevention of intestinal adenomatous polyposis in APC(Min/+) mice. Drug Discov Ther 8:25–32

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This project was supported by the Natural Science Foundation of China (91229113, 81173090, 81373435) and the Natural Science Foundation of Shandong (ZR2009CQ019).

Author information

Authors and Affiliations

  1. School of Pharmaceutical Sciences, Shandong University, Jinan, China

    Yu-Sheng Zhang & Xian-Jun Qu

  2. Department of Pharmacology, School of Chemical Biology & Pharmaceutical Sciences, Capital Medical University, Beijing, China

    Ye Li

  3. Department of Pharmacology, Institute of Materia Medica, Shandong Academy of Medical Sciences, Jinan, China

    Yan Wang

  4. Department of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, China

    Shi-Yue Sun, Cong Li, Shu-Xiang Cui & Xian-Jun Qu

  5. Shandong Tumor Hospital, Jinan, China

    Tao Jiang

Authors
  1. Yu-Sheng Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ye Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shi-Yue Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tao Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Cong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shu-Xiang Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Xian-Jun Qu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xian-Jun Qu.

Ethics declarations

Conflict of interest

We confirm that there is no potential conflict of interest or financial dependence regarding this paper.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, YS., Li, Y., Wang, Y. et al. Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc Min/+ mouse model. J Cancer Res Clin Oncol 142, 913–925 (2016). https://doi.org/10.1007/s00432-015-2097-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-015-2097-9

Keywords

Search

Navigation